366 related articles for article (PubMed ID: 18829534)
1. Runx2 transcriptional activation of Indian Hedgehog and a downstream bone metastatic pathway in breast cancer cells.
Pratap J; Wixted JJ; Gaur T; Zaidi SK; Dobson J; Gokul KD; Hussain S; van Wijnen AJ; Stein JL; Stein GS; Lian JB
Cancer Res; 2008 Oct; 68(19):7795-802. PubMed ID: 18829534
[TBL] [Abstract][Full Text] [Related]
2. Wnt signaling induces gene expression of factors associated with bone destruction in lung and breast cancer.
Johnson RW; Merkel AR; Page JM; Ruppender NS; Guelcher SA; Sterling JA
Clin Exp Metastasis; 2014 Dec; 31(8):945-59. PubMed ID: 25359619
[TBL] [Abstract][Full Text] [Related]
3. TGF-beta promotion of Gli2-induced expression of parathyroid hormone-related protein, an important osteolytic factor in bone metastasis, is independent of canonical Hedgehog signaling.
Johnson RW; Nguyen MP; Padalecki SS; Grubbs BG; Merkel AR; Oyajobi BO; Matrisian LM; Mundy GR; Sterling JA
Cancer Res; 2011 Feb; 71(3):822-31. PubMed ID: 21189326
[TBL] [Abstract][Full Text] [Related]
4. The hedgehog signaling molecule Gli2 induces parathyroid hormone-related peptide expression and osteolysis in metastatic human breast cancer cells.
Sterling JA; Oyajobi BO; Grubbs B; Padalecki SS; Munoz SA; Gupta A; Story B; Zhao M; Mundy GR
Cancer Res; 2006 Aug; 66(15):7548-53. PubMed ID: 16885353
[TBL] [Abstract][Full Text] [Related]
5. ITGBL1 Is a Runx2 Transcriptional Target and Promotes Breast Cancer Bone Metastasis by Activating the TGFβ Signaling Pathway.
Li XQ; Du X; Li DM; Kong PZ; Sun Y; Liu PF; Wang QS; Feng YM
Cancer Res; 2015 Aug; 75(16):3302-13. PubMed ID: 26060017
[TBL] [Abstract][Full Text] [Related]
6. Targeting of Runx2 by miR-135 and miR-203 Impairs Progression of Breast Cancer and Metastatic Bone Disease.
Taipaleenmäki H; Browne G; Akech J; Zustin J; van Wijnen AJ; Stein JL; Hesse E; Stein GS; Lian JB
Cancer Res; 2015 Apr; 75(7):1433-44. PubMed ID: 25634212
[TBL] [Abstract][Full Text] [Related]
7. Gut-derived serotonin induced by depression promotes breast cancer bone metastasis through the RUNX2/PTHrP/RANKL pathway in mice.
Zong JC; Wang X; Zhou X; Wang C; Chen L; Yin LJ; He BC; Deng ZL
Oncol Rep; 2016 Feb; 35(2):739-48. PubMed ID: 26573960
[TBL] [Abstract][Full Text] [Related]
8. PTHrP regulates angiogenesis and bone resorption via VEGF expression.
Isowa S; Shimo T; Ibaragi S; Kurio N; Okui T; Matsubara K; Hassan NM; Kishimoto K; Sasaki A
Anticancer Res; 2010 Jul; 30(7):2755-67. PubMed ID: 20683010
[TBL] [Abstract][Full Text] [Related]
9. Runx2 induces bone osteolysis by transcriptional suppression of TSSC1.
Wang DC; Wang HF; Yuan ZN
Biochem Biophys Res Commun; 2013 Sep; 438(4):635-9. PubMed ID: 23933319
[TBL] [Abstract][Full Text] [Related]
10. Role of Runx2 in IGF-1Rβ/Akt- and AMPK/Erk-dependent growth, survival and sensitivity towards metformin in breast cancer bone metastasis.
Tandon M; Chen Z; Othman AH; Pratap J
Oncogene; 2016 Sep; 35(36):4730-40. PubMed ID: 26804175
[TBL] [Abstract][Full Text] [Related]
11. Discoidin domain receptor 2 facilitates prostate cancer bone metastasis via regulating parathyroid hormone-related protein.
Yan Z; Jin S; Wei Z; Huilian H; Zhanhai Y; Yue T; Juan L; Jing L; Libo Y; Xu L
Biochim Biophys Acta; 2014 Sep; 1842(9):1350-63. PubMed ID: 24787381
[TBL] [Abstract][Full Text] [Related]
12. Indian hedgehog signaling regulates transcription and expression of collagen type X via Runx2/Smads interactions.
Amano K; Densmore M; Nishimura R; Lanske B
J Biol Chem; 2014 Sep; 289(36):24898-910. PubMed ID: 25028519
[TBL] [Abstract][Full Text] [Related]
13. The Runx2 osteogenic transcription factor regulates matrix metalloproteinase 9 in bone metastatic cancer cells and controls cell invasion.
Pratap J; Javed A; Languino LR; van Wijnen AJ; Stein JL; Stein GS; Lian JB
Mol Cell Biol; 2005 Oct; 25(19):8581-91. PubMed ID: 16166639
[TBL] [Abstract][Full Text] [Related]
14. Ihh/Gli2 signaling promotes osteoblast differentiation by regulating Runx2 expression and function.
Shimoyama A; Wada M; Ikeda F; Hata K; Matsubara T; Nifuji A; Noda M; Amano K; Yamaguchi A; Nishimura R; Yoneda T
Mol Biol Cell; 2007 Jul; 18(7):2411-8. PubMed ID: 17442891
[TBL] [Abstract][Full Text] [Related]
15. Transforming growth factor-beta in osteolytic breast cancer bone metastases.
Guise TA; Chirgwin JM
Clin Orthop Relat Res; 2003 Oct; (415 Suppl):S32-8. PubMed ID: 14600590
[TBL] [Abstract][Full Text] [Related]
16. Regulatory roles of Runx2 in metastatic tumor and cancer cell interactions with bone.
Pratap J; Lian JB; Javed A; Barnes GL; van Wijnen AJ; Stein JL; Stein GS
Cancer Metastasis Rev; 2006 Dec; 25(4):589-600. PubMed ID: 17165130
[TBL] [Abstract][Full Text] [Related]
17. The role of Runx2 in facilitating autophagy in metastatic breast cancer cells.
Tandon M; Othman AH; Ashok V; Stein GS; Pratap J
J Cell Physiol; 2018 Jan; 233(1):559-571. PubMed ID: 28345763
[TBL] [Abstract][Full Text] [Related]
18. Breast cancer cells induce osteoclast formation by stimulating host IL-11 production and downregulating granulocyte/macrophage colony-stimulating factor.
Morgan H; Tumber A; Hill PA
Int J Cancer; 2004 May; 109(5):653-60. PubMed ID: 14999770
[TBL] [Abstract][Full Text] [Related]
19. Molecular mechanisms of tumor-bone interactions in osteolytic metastases.
Chirgwin JM; Guise TA
Crit Rev Eukaryot Gene Expr; 2000; 10(2):159-78. PubMed ID: 11186331
[TBL] [Abstract][Full Text] [Related]
20. TGF-beta signaling blockade inhibits PTHrP secretion by breast cancer cells and bone metastases development.
Yin JJ; Selander K; Chirgwin JM; Dallas M; Grubbs BG; Wieser R; Massagué J; Mundy GR; Guise TA
J Clin Invest; 1999 Jan; 103(2):197-206. PubMed ID: 9916131
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
